Japan Strengthens Regenerative Medicine Oversight

Douglas Sipp; Hideyuki Okano

doi:10.1016/j.stem.2018.01.001

Japan Strengthens Regenerative Medicine Oversight

Douglas Sipp, Hideyuki Okano

Department of Physiology

Research output: Contribution to journal › Comment/debate › peer-review

14 Citations (Scopus)

Abstract

The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy. The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.

Original language	English
Pages (from-to)	153-156
Number of pages	4
Journal	Cell stem cell
Volume	22
Issue number	2
DOIs	https://doi.org/10.1016/j.stem.2018.01.001
Publication status	Published - 2018 Feb 1

ASJC Scopus subject areas

Molecular Medicine
Genetics
Cell Biology

Access to Document

10.1016/j.stem.2018.01.001

Fingerprint Dive into the research topics of 'Japan Strengthens Regenerative Medicine Oversight'. Together they form a unique fingerprint.

Cite this

@article{83910fac4a5440f799cc975078f6bbc5,

title = "Japan Strengthens Regenerative Medicine Oversight",

abstract = "The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy. The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.",

author = "Douglas Sipp and Hideyuki Okano",

note = "Funding Information: The present study was partly supported by a grant “Project to Build Foundation for Promoting Clinical Research of Regenerative Medicine” from AMED (Grant No. 17bk0204001s0102 ). ",

year = "2018",

month = feb,

day = "1",

doi = "10.1016/j.stem.2018.01.001",

language = "English",

volume = "22",

pages = "153--156",

journal = "Cell Stem Cell",

issn = "1934-5909",

publisher = "Cell Press",

number = "2",

}

TY - JOUR

T1 - Japan Strengthens Regenerative Medicine Oversight

AU - Sipp, Douglas

AU - Okano, Hideyuki

N1 - Funding Information: The present study was partly supported by a grant “Project to Build Foundation for Promoting Clinical Research of Regenerative Medicine” from AMED (Grant No. 17bk0204001s0102 ).

PY - 2018/2/1

Y1 - 2018/2/1

N2 - The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy. The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.

AB - The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy. The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.

UR - http://www.scopus.com/inward/record.url?scp=85045558136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045558136&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2018.01.001

DO - 10.1016/j.stem.2018.01.001

M3 - Comment/debate

C2 - 29395052

AN - SCOPUS:85045558136

VL - 22

SP - 153

EP - 156

JO - Cell Stem Cell

JF - Cell Stem Cell

SN - 1934-5909

IS - 2

ER -